Structural linkage between ligand discrimination and receptor activation by type I interferons

Cell. 2011 Aug 19;146(4):621-32. doi: 10.1016/j.cell.2011.06.048.

Abstract

Type I Interferons (IFNs) are important cytokines for innate immunity against viruses and cancer. Sixteen human type I IFN variants signal through the same cell-surface receptors, IFNAR1 and IFNAR2, yet they can evoke markedly different physiological effects. The crystal structures of two human type I IFN ternary signaling complexes containing IFNα2 and IFNω reveal recognition modes and heterotrimeric architectures that are unique among the cytokine receptor superfamily but conserved between different type I IFNs. Receptor-ligand cross-reactivity is enabled by conserved receptor-ligand "anchor points" interspersed among ligand-specific interactions that "tune" the relative IFN-binding affinities, in an apparent extracellular "ligand proofreading" mechanism that modulates biological activity. Functional differences between IFNs are linked to their respective receptor recognition chemistries, in concert with a ligand-induced conformational change in IFNAR1, that collectively control signal initiation and complex stability, ultimately regulating differential STAT phosphorylation profiles, receptor internalization rates, and downstream gene expression patterns.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Cell Line, Tumor
  • Crystallography, X-Ray
  • Humans
  • Interferon Type I / chemistry*
  • Interferon Type I / metabolism
  • Interferon-alpha / chemistry*
  • Interferon-alpha / metabolism
  • Ligands
  • Models, Molecular
  • Molecular Sequence Data
  • Receptors, Interferon / metabolism*
  • Sequence Alignment

Substances

  • Interferon Type I
  • Interferon-alpha
  • Ligands
  • Receptors, Interferon
  • interferon omega 1

Associated data

  • PDB/3S8W
  • PDB/3S98
  • PDB/3S9D
  • PDB/3SE3
  • PDB/3SE4